Focal therapy is emerging as an alternative to active surveillance for the management of low-
risk prostate cancer in carefully selected patients. The aim of focal therapy is long-term …

Globally, the increased uptake of serum PSA level screening led to an increase in the
number of diagnoses of low-risk and intermediate-risk prostate cancer. Traditionally, these …

A widespread screening with prostate‐specific antigen (PSA) has led increased diagnosis of
localized prostate cancer along with a reduction in the proportion of advanced‐stage …

Focal therapy is an emerging treatment modality for localised prostate cancer that aims to
reduce the morbidity seen with radical therapy, while maintaining cancer control. Focal …

PURPOSE: Based on contemporary epidemiological and pathological characteristics of
prostate cancer we explain the rationale for and concerns about focal therapy for low risk …

INTRODUCTION: The aim of this study was to review the oncological and functional
outcomes of new and established primary focal treatments (FT) for localized prostate cancer …

The proportion of men with low-to intermediate-risk prostate cancer is rising with the
increasing use of formal and informal prostate-specific antigen screening. The risk-to-benefit …

Background Focal therapy has been introduced for the treatment of localised prostate
cancer (PCa). To provide the necessary data for consistent assessment, all focal therapy …

Focal therapy is an appealing strategy for any tumor and in time may prove to be a valuable
treatment option for low-risk, carefully selected prostate cancer (PCa) patients. In an era …

Introduction Focal therapy for prostate cancer is a radical paradigm shift in the management
of men with localised prostate cancer. It involves locating and destroying only the areas of …